Inventor · disambiguated record
Hwan Geun Choi
Also filed as: CHOI HWAN G · CHOI HWAN GEUN
55 granted patents·16 pending applications·357 citations·filing 2009–2023
98Inventor score
Files withDANA FARBER CANCER INST INC32DAEGU GYEONGBUK MEDICAL INNOVATION FOUND8VORONOI INC7KOREA INST SCI & TECH5MASSACHUSETTS GEN HOSPITAL5
Top patents by PatentIndex Score
71 records- 0197US9505784B2Fused 2-aminothiazole compoundsDANA FARBER CANCER INST INC·Filed 2014·Granted Nov 29, 2016·64 cites·27 claims
- 0295US11725011B2Bicyclic urea kinase inhibitors and uses thereofBROAD INST INC·Filed 2020·Granted Aug 15, 2023·4 cites·9 claims
- 0395US10287268B2Imidazolyl kinase inhibitors and uses thereofDANA FARBER CANCER INST INC·Filed 2015·Granted May 14, 2019·11 cites·23 claims
- 0494US10544138B2Tricyclic kinase inhibitors of MELK and methods of useDANA FARBER CANCER INST INC·Filed 2016·Granted Jan 28, 2020·12 cites·20 claims
- 0593US10975058B2Imidazolyl kinase inhibitors and uses thereofDANA FARBER CANCER INST INC·Filed 2019·Granted Apr 13, 2021·6 cites·32 claims
- 0693US9358231B2Type II RAF kinase inhibitorsDANA FARBER CANCER INST INC·Filed 2014·Granted Jun 7, 2016·22 cites·1 claims
- 0793US9180127B2Type II Raf kinase inhibitorsGRAY NATHANAEL S·Filed 2010·Granted Nov 10, 2015·24 cites·8 claims
- 0892US11466000B2Heteroaryl derivative, method for producing same, and pharmaceutical composition comprising same as effective componentVORONOI INC·Filed 2021·Granted Oct 11, 2022·5 cites·39 claims
- 0992US10233157B2SIK inhibitor for use in a method of treating an inflammatory and/or immune disorderDANA FARBER CANCER INST INC·Filed 2017·Granted Mar 19, 2019·9 cites·26 claims
- 1092US9783504B2Kinase inhibitors for the treatment of diseaseDANA FARBER CANCER INST INC·Filed 2014·Granted Oct 10, 2017·21 cites·27 claims
- 1191US10265321B2Uses of salt-inducible kinase (SIK) inhibitorsDANA FARBER CANCER INST INC·Filed 2017·Granted Apr 23, 2019·10 cites·38 claims
- 1291US9670165B2SIK inhibitor for use in a method of treating an inflammatory and/or immune disorderUNIV COURT OF THE UNIV OF DUNDEE·Filed 2013·Granted Jun 6, 2017·33 cites·20 claims
- 1391US8765747B2Fused 2-aminothiazole compoundsCHOI HWAN GEUN·Filed 2010·Granted Jul 1, 2014·33 cites·31 claims
- 1491US8754209B2Indazole derivatives or pharmaceutically acceptable salts thereof as protein kinase inhibitors for proliferative diseases treatment, and a pharmaceutical composition containing the same as an active ingredientSIM TAE BO·Filed 2009·Granted Jun 17, 2014·30 cites·8 claims
- 1590US10954242B2Bicyclic urea kinase inhibitors and uses thereofBROAD INST INC·Filed 2017·Granted Mar 23, 2021·9 cites·33 claims
- 1690US10316002B2Kinase inhibitors for the treatment of diseaseDANA FARBER CANCER INST INC·Filed 2017·Granted Jun 11, 2019·9 cites·18 claims
- 1788US10457691B2Macrocyclic kinase inhibitors and uses thereofDANA FARBER CANCER INST INC·Filed 2015·Granted Oct 29, 2019·9 cites·38 claims
- 1887US11208412B2Pyrrolo-pyrimidine derivative compound, preparation method therefor, and pharmaceutical composition comprising same compound as effective ingredient for preventing or treating protein kinase-related diseaseDAEGU GYEONGBUK MEDICAL INNOVATION FOUND·Filed 2018·Granted Dec 28, 2021·2 cites·7 claims
- 1986US11826365B2Type II raf kinase inhibitorsDANA FARBER CANCER INST INC·Filed 2020·Granted Nov 28, 2023·1 cites·8 claims
- 2085US10112957B2Thiazolyl-containing compounds for treating proliferative diseasesDANA FARBER CANCER INST INC·Filed 2015·Granted Oct 30, 2018·5 cites·35 claims
- 2185US8329708B21,3,6-substituted indole derivatives having inhibitory activity for protein kinaseSIM TAE BO·Filed 2010·Granted Dec 11, 2012·5 cites·11 claims
- 2284US12157730B2Heteroaryl derivative, method for producing same, and pharmaceutical composition comprising same as effective componentVORONOI INC·Filed 2022·Granted Dec 3, 2024·1 cites·43 claims
- 2384US11117892B2Pyrrolo-pyridine derivative compound, method for preparing same, and pharmaceutical composition containing same as active ingredient for prevention or treatment of protein kinase-related diseasesDAEGU GYEONGBUK MEDICAL INNOVATION FOUND·Filed 2018·Granted Sep 14, 2021·3 cites·9 claims
- 2482US12331037B2Pyrimidines as EGFR-inhibitors and methods of treating disordersDANA FARBER CANCER INST INC·Filed 2023·Granted Jun 17, 2025·0 cites·16 claims
- 2581US11285158B2Uses of pyrimidopyrimidinones as SIK inhibitorsMASSACHUSETTS GEN HOSPITAL·Filed 2018·Granted Mar 29, 2022·1 cites·47 claims
- 2681US10870647B2Imidazopyridine derivative, method for preparing same, and pharmaceutical composition containing same as active ingredient for preventing or treating cancerDAEGU GYEONGBUK MEDICAL INNOVATION FOUND·Filed 2017·Granted Dec 22, 2020·1 cites·21 claims
- 2781US8586580B22,7-substituted thieno[3,2-d] pyrimidine compounds as protein kinase inhibitorsSIM TAE BO·Filed 2010·Granted Nov 19, 2013·8 cites·7 claims
- 2880US10913744B2LRRK2 inhibitors and methods of making and using the sameDANA FARBER CANCER INST INC·Filed 2016·Granted Feb 9, 2021·3 cites·21 claims
- 2980US10464949B2Thiazolyl-containing compounds for treating proliferative diseasesDANA FARBER CANCER INST INC·Filed 2018·Granted Nov 5, 2019·2 cites·32 claims
- 3080US10266517B2Pyrimidines as EGFR inhibitors and methods of treating disordersDANA FARBER CANCER INST INC·Filed 2015·Granted Apr 23, 2019·2 cites·18 claims
- 3179US12398145B2Bicyclic urea kinase inhibitors and uses thereofBROAD INST INC·Filed 2023·Granted Aug 26, 2025·0 cites·47 claims
- 3279US11241435B2Uses of salt-inducible kinase (SIK) inhibitors for treating osteoporosisMASSACHUSETTS GEN HOSPITAL·Filed 2017·Granted Feb 8, 2022·1 cites·27 claims
- 3379US10836722B2Inhibitors of EGFR and methods of use thereofDANA FARBER CANCER INST INC·Filed 2019·Granted Nov 17, 2020·1 cites·18 claims
- 3478US10385019B2Inhibitors of EGFR and methods of use thereofDANA FARBER CANCER INST INC·Filed 2016·Granted Aug 20, 2019·2 cites·21 claims
- 3578US8765749B21,6-disubstituted indole compounds as protein kinase inhibitorsSIM TAE BO·Filed 2010·Granted Jul 1, 2014·3 cites·7 claims
- 3678US2024245695A1Uses of pyrimidopyrimidinones as sik inhibitorsMASSACHUSETTS GEN HOSPITAL·Filed 2023·Application pending·0 cites
- 3773US8648089B21,3,6-substituted indole derivatives having inhibitory activity for protein kinaseKOREA INST SCI & TECH·Filed 2012·Granted Feb 11, 2014·1 cites·3 claims
- 3873US2023248740A1Pharmaceutical Composition Comprising Compound Capable of Penetrating Blood-Brain Barrier as Effective Ingredient for Preventing or Treating Brain CancerDAEGU GYEONGBUK MEDICAL INNOVATION FOUND·Filed 2022·Application pending·0 cites
- 3973US2023181596A1Pharmaceutical Composition Comprising Compound Capable of Penetrating Blood-Brain Barrier as Effective Ingredient for Preventing or Treating Brain CancerDAEGU GYEONGBUK MEDICAL INNOVATION FOUND·Filed 2022·Application pending·0 cites
- 4072US10442796B22,3,5-substituted thiophene compound as protein kinase inhibitorKOREA INST SCI & TECH·Filed 2018·Granted Oct 15, 2019·1 cites·8 claims
- 4171US11673882B2Pyrimidines as EGFR inhibitors and methods of treating disordersDANA FARBER CANCER INST INC·Filed 2020·Granted Jun 13, 2023·0 cites·16 claims
- 4270US11878019B2Uses of pyrimidopyrimidinones as SIK inhibitorsMASSACHUSETTS GEN HOSPITAL·Filed 2021·Granted Jan 23, 2024·0 cites·25 claims
- 4370US2024150337A1Heteroaryl derivative, method for producing same, and pharmaceutical composition comprising same as effective componentVORONOI INC·Filed 2023·Application pending·0 cites
- 4469US12209076B2Imidazolyl kinase inhibitors and uses thereofDANA FARBER CANCER INST INC·Filed 2021·Granted Jan 28, 2025·0 cites·19 claims
- 4567US2020338087A9Uses of salt-inducible kinase (sik) inhibitorsDANA FARBER CANCER INST INC·Filed 2019·Application pending·0 cites
- 4666US8999973B2Thieno[3,2-d]pyrimidine derivatives having inhibitory activity on protein kinasesSON JUNG BEOM·Filed 2011·Granted Apr 7, 2015·2 cites·14 claims
- 4766US2021094913A1Inhibitors of egfr and methods of use thereofDANA FARBER CANCER INST INC·Filed 2020·Application pending·0 cites
- 4865US12121521B2Uses of salt-inducible kinase (SIK) inhibitors for treating osteoporosisMASSACHUSETTS GEN HOSPITAL·Filed 2022·Granted Oct 22, 2024·0 cites·46 claims
- 4965US10906878B2Kinase inhibitors for the treatment of diseaseDANA FARBER CANCER INST INC·Filed 2019·Granted Feb 2, 2021·0 cites·20 claims
- 5064US10870636B2Pyrimidines as EGFR inhibitors and methods of treating disordersDANA FARBER CANCER INST INC·Filed 2019·Granted Dec 22, 2020·0 cites·18 claims
Showing the top 50 of 71 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when Hwan Geun Choi files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →